Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Wen‐Bin Zou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7881-0156; OpenAlex author ID A5113810807. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 10

  1. Single-cell RNA sequencing and high-dimensional flow cytometry reveal distinct peripheral immune landscapes of type 1 autoimmune pancreatitis and pancreatic du… Co-author DOI 10.1002/ctm2.70680↗
  2. Global, regional, and national burdens of pancreatic cancer and pancreatitis among older adults from 1990 to 2021: A comparative investigation. Co-author DOI 10.1016/j.pan.2026.07.012↗
  3. Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analy… Co-author DOI 10.1016/j.tranon.2026.102674↗
  4. Germline mutations and pancreatic cancer risk in chronic pancreatitis. Last author DOI 10.1136/gutjnl-2024-334277↗
  5. Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer. First author DOI 10.1186/s40246-025-00740-x↗
  6. Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma. Co-author DOI 10.1002/ijc.34334↗
  7. SPINK1 mutations and risk of pancreatic cancer in a Chinese cohort. Co-author DOI 10.1016/j.pan.2021.05.304↗
  8. The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data. Co-author DOI 10.3389/fonc.2021.651350↗
  9. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2019-318860↗
  10. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: A cohort of 1656 patients. Co-author DOI 10.1016/j.dld.2017.07.001↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhuan Liao · 6 shared papers, 2017–2026 · strength 1.22
  2. Lei Wang · 2 shared papers, 2021–2026 · strength 0.42
  3. Lei Huang · 1 shared paper, 2026 · strength 0.36
  4. Zhaoshen Li · 1 shared paper, 2026 · strength 0.36
  5. Jian‐Min Chen · 1 shared paper, 2025 · strength 0.30
  6. Qi-Wen Wang · 1 shared paper, 2025 · strength 0.30
  7. Di Wu · 1 shared paper, 2026 · strength 0.29
  8. Peng Wang · 2 shared papers, 2020–2023 · strength 0.28
  9. Zhiqiang Meng · 2 shared papers, 2020–2023 · strength 0.28
  10. Suizhi Gao · 1 shared paper, 2025 · strength 0.27
  11. Zipeng Lu · 1 shared paper, 2025 · strength 0.27
  12. Hao Wu · 1 shared paper, 2025 · strength 0.27
  13. Gang Jin · 1 shared paper, 2025 · strength 0.27
  14. Chunhua Zhou · 1 shared paper, 2026 · strength 0.23
  15. Youqiong Ye · 1 shared paper, 2026 · strength 0.23
  16. Chenxiao Liu · 1 shared paper, 2026 · strength 0.23
  17. Tingting Gong · 1 shared paper, 2026 · strength 0.23
  18. Changjing Huang · 1 shared paper, 2023 · strength 0.19
  19. Zhouyu Ning · 1 shared paper, 2023 · strength 0.19
  20. Liping Zhuang · 1 shared paper, 2023 · strength 0.19
  21. Chien‐shan Cheng · 1 shared paper, 2023 · strength 0.19
  22. Liang‐Hao Hu · 2 shared papers, 2017–2021 · strength 0.18
  23. Yue Mei · 1 shared paper, 2021 · strength 0.16
  24. Dong Su Yu · 1 shared paper, 2021 · strength 0.16
  25. Shiwei Guo · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.